[DISCLOSURE]
ST Pharm (237690) reported on July 26 that its second-quarter operating profit soared 548.2 percent to 31.21 billion won (US$27.48 million) from the same period last year. Its sales leaped 129.8 percent to 69.77 billion won and net profit surged 621.5 percent to 23.72 billion won.
